Completed PHASE2 INTERVENTIONAL 2-arm NCT01348152

Effect of TU-100 in Patients With Functional Constipation

A Randomized, Double-Blinded, Placebo-Controlled Exploratory Study of Daikenchuto (TU-100) in Patients With Functional Constipation

Sponsor: Cato Research

Conditions Functional Constipation

Interventions DAIKENCHUTO (TU-100) Placebo

Updated 7 times since 2017 Last updated: Sep 9, 2013 Started: Sep 30, 2011 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Functional Constipation and is currently completed. Cato Research leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cato Research
Tsumura USA

Data source: Tsumura USA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States